Supplier Details
Wuhan Sun-shine chemical Corporation Limited
Contact: Ms.Luna WangTel: 86--18312560332Total Annual Sales Volume: US$1 Million - US$2.5 MillionNumber of Employees: 11 - 50 PeopleBusiness Type: Manufacturer,Trading CompanyMain Markets: North America,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Western Europe
View the Seller's Store
Product Details
Company Profile
Item specifics
Product Name.: LGX-818CAS No: 1269440-17-6
Details
Encorafenib, also known as LGX818 is a drug candidate for the treatment of melanoma with the V600E mutation in the B-RAF kinase. The substance is being developed by Novartis and was disclosed at the spring 2013 American Chemical Society meeting in New Orleans.
Permanent link: http://www.vvchem.com/sell/cas:1269440-17-6,3524953.html
Basic Information
Business Type: Manufacturer,Trading CompanyProduct/Service (We Buy): 11 - 50 PeopleOwnership Type: LLC (Ltd Liability Corp)Registered Capital: US$101 Thousand - US$500 ThousandYear Established: 2012Number of Employees: 11 - 50 People
Trade & Market
Main Markets: North America,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Western EuropeQA/QC: Third PartiesNumber of Production Lines: 5Number of R&D Staff: 96Number of QC Staff: Less than 5 PeopleTotal Annual Sales Volume: US$1 Million - US$2.5 MillionExport Percentage: 41% - 50%Export Percentage: Below US$1 Million
Factory Information
Factory Size (Sq.meters): Below 1,000 square metersManagement Certification: ISO 17799Contract Manufacturing: OEM Service OfferedYears of OEM Experience: 5 Year(s)
Send message to this supplier
China